Roivant Sciences Stock EBITDA

ROIV Stock  USD 10.85  0.19  1.78%   
Roivant Sciences fundamentals help investors to digest information that contributes to Roivant Sciences' financial success or failures. It also enables traders to predict the movement of Roivant Stock. The fundamental analysis module provides a way to measure Roivant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roivant Sciences stock.
Last ReportedProjected for Next Year
EBITDAB5.2 B
EBITDA is likely to climb to about 5.2 B in 2025.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Roivant Sciences Company EBITDA Analysis

Roivant Sciences' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Roivant Sciences EBITDA

    
  4.31 B  
Most of Roivant Sciences' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roivant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Roivant EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Roivant Sciences is extremely important. It helps to project a fair market value of Roivant Stock properly, considering its historical fundamentals such as EBITDA. Since Roivant Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Roivant Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Roivant Sciences' interrelated accounts and indicators.
1.00.410.37-0.980.90.940.980.771.00.080.510.84-0.80.710.98-0.870.980.810.88-0.94-0.9
1.00.420.33-0.980.920.920.970.741.00.030.510.82-0.760.680.98-0.880.980.790.87-0.95-0.9
0.410.420.58-0.420.340.450.260.140.39-0.390.890.17-0.360.310.24-0.080.250.140.2-0.18-0.31
0.370.330.58-0.34-0.020.650.350.580.330.410.520.51-0.770.750.190.080.190.510.42-0.18-0.25
-0.98-0.98-0.42-0.34-0.91-0.91-0.94-0.76-0.98-0.01-0.53-0.840.78-0.72-0.950.83-0.95-0.8-0.830.960.8
0.90.920.34-0.02-0.910.70.850.50.91-0.240.450.62-0.480.40.93-0.920.930.580.69-0.9-0.81
0.940.920.450.65-0.910.70.920.870.930.260.510.9-0.940.880.86-0.680.870.870.88-0.85-0.81
0.980.970.260.35-0.940.850.920.820.980.270.420.89-0.80.70.97-0.890.970.880.93-0.94-0.9
0.770.740.140.58-0.760.50.870.820.750.550.350.97-0.870.890.71-0.610.710.970.91-0.79-0.58
1.01.00.390.33-0.980.910.930.980.750.070.490.83-0.780.690.98-0.880.980.80.88-0.95-0.91
0.080.03-0.390.41-0.01-0.240.260.270.550.07-0.170.48-0.410.390.07-0.070.060.560.41-0.1-0.1
0.510.510.890.52-0.530.450.510.420.350.49-0.170.36-0.360.320.35-0.30.350.370.37-0.33-0.35
0.840.820.170.51-0.840.620.90.890.970.830.480.36-0.880.890.8-0.70.80.990.94-0.88-0.65
-0.8-0.76-0.36-0.770.78-0.48-0.94-0.8-0.87-0.78-0.41-0.36-0.88-0.96-0.70.46-0.71-0.85-0.80.720.64
0.710.680.310.75-0.720.40.880.70.890.690.390.320.89-0.960.61-0.370.610.850.78-0.69-0.49
0.980.980.240.19-0.950.930.860.970.710.980.070.350.8-0.70.61-0.931.00.770.86-0.96-0.92
-0.87-0.88-0.080.080.83-0.92-0.68-0.89-0.61-0.88-0.07-0.3-0.70.46-0.37-0.93-0.93-0.7-0.810.90.85
0.980.980.250.19-0.950.930.870.970.710.980.060.350.8-0.710.611.0-0.930.760.86-0.96-0.92
0.810.790.140.51-0.80.580.870.880.970.80.560.370.99-0.850.850.77-0.70.760.94-0.84-0.65
0.880.870.20.42-0.830.690.880.930.910.880.410.370.94-0.80.780.86-0.810.860.94-0.87-0.81
-0.94-0.95-0.18-0.180.96-0.9-0.85-0.94-0.79-0.95-0.1-0.33-0.880.72-0.69-0.960.9-0.96-0.84-0.870.78
-0.9-0.9-0.31-0.250.8-0.81-0.81-0.9-0.58-0.91-0.1-0.35-0.650.64-0.49-0.920.85-0.92-0.65-0.810.78
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

Roivant Ebitda

Ebitda

5.2 Billion

At this time, Roivant Sciences' EBITDA is fairly stable compared to the past year.
According to the company disclosure, Roivant Sciences reported earnings before interest,tax, depreciation and amortization of 4.31 B. This is 391.23% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 10.56% lower than that of the firm.

Roivant EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roivant Sciences' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Roivant Sciences could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics of similar companies.
Roivant Sciences is currently under evaluation in ebitda category among its peers.

Roivant Sciences Current Valuation Drivers

We derive many important indicators used in calculating different scores of Roivant Sciences from analyzing Roivant Sciences' financial statements. These drivers represent accounts that assess Roivant Sciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Roivant Sciences' important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Market Cap6.7B3.3B5.3B8.2B7.4B4.1B
Enterprise Value4.9B1.5B4.1B2.1B1.9B2.1B

Roivant Sciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Roivant Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Roivant Sciences' managers, analysts, and investors.
Environmental
Governance
Social

Roivant Sciences Institutional Holders

Institutional Holdings refers to the ownership stake in Roivant Sciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Roivant Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Roivant Sciences' value.
Shares
Amvescap Plc.2024-12-31
9.5 M
Geode Capital Management, Llc2024-12-31
7.8 M
Woodline Partners Lp2024-12-31
6.1 M
Toms Capital Investment Management Lp2024-12-31
5.9 M
Adage Capital Partners Gp Llc2024-12-31
5.7 M
Ubs Group Ag2024-12-31
5.3 M
Anchorage Advisors, Llc2024-12-31
4.8 M
Norges Bank2024-12-31
4.4 M
Blackbarn Capital Partners Lp2024-12-31
4.1 M
Qvt Financial Lp2024-12-31
65.8 M
Sb Investment Advisers (uk) Ltd2024-12-31
62.1 M

Roivant Fundamentals

About Roivant Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Roivant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roivant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roivant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.